Related references
Note: Only part of the references are listed.Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)
Jana Pachlopnik Schmid et al.
BLOOD (2011)
A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
David S. Kotlyar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Increased Risk of Nonmelanoma Skin Cancers Among Individuals With Inflammatory Bowel Disease
Harminder Singh et al.
GASTROENTEROLOGY (2011)
Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
Laurent Peyrin-Biroulet et al.
GASTROENTEROLOGY (2011)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
Millie D. Long et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Risk of Lymphoma Associated With Combination Anti-Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
Corey A. Siegel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Risk of Cervical Abnormalities in Women With Inflammatory Bowel Disease: A Population-Based Nested Case-Control Study
Harminder Singh et al.
GASTROENTEROLOGY (2009)
Patients With Drug-Induced Microscopic Colitis Should Not Be Included in Controlled Trials Assessing the Efficacy of Anti-Inflammatory Drugs in Microscopic Colitis
Laurent Beaugerie et al.
GASTROENTEROLOGY (2009)
Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle
H. Sokol et al.
GUT (2009)
Epstein-Barr Virus-associated Lymphoproliferation Awareness in Hemophagocytic Syndrome Complicating Thiopurine Treatment for Crohn's Disease
C. Serrate et al.
INFLAMMATORY BOWEL DISEASES (2009)
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
J. F. Rahier et al.
JOURNAL OF CROHNS & COLITIS (2009)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease
Sunanda Kane et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Azathioprine treatment photosensitizes human skin to ultraviolet A radiation
C. M. Perrett et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Abnormal pap smears in inflammatory bowel disease
Sunanda Kane
INFLAMMATORY BOWEL DISEASES (2008)
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation
P. Comoli et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Immunosuppressive therapy and malignancy in organ transplant recipients - A systematic review
Alex Gutierrez-Dalmau et al.
DRUGS (2007)
Abnormalities of uterine cervix in women with inflammatory bowel disease
Jyoti Bhatia et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development
DM Weinstock et al.
BONE MARROW TRANSPLANTATION (2006)
Azathioprine and UVA light generate mutagenic oxidative DNA damage
P O'Donovan et al.
SCIENCE (2005)
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
A Kandiel et al.
GUT (2005)
Epstein-Barr virus viral load in Crohn's disease - Effect of immunosuppressive therapy
D Reijasse et al.
INFLAMMATORY BOWEL DISEASES (2004)
Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales
MC Morris et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Screening for solid organ malignancies prior to heart transplantation
VM Conraads et al.
TRANSPLANTATION (2001)
Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients
SJC Stevens et al.
BLOOD (2001)